Acropolis Investment Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,616
| Closed | -$102K | – | 306 |
|
|
2024
Q3 | $102K | Sell |
1,616
-444
| -22% | -$25.9K | 0.01% | 296 |
|
|
2024
Q2 | $122K | Buy |
2,060
+5
| +0.2% | +$313 | 0.01% | 266 |
|
|
2024
Q1 | $164K | Sell |
2,055
-291
| -12% | -$22.2K | 0.01% | 234 |
|
|
2023
Q4 | $185K | Buy |
2,346
+1
| +0% | +$71 | 0.01% | 226 |
|
|
2023
Q3 | $164K | Sell |
2,345
-398
| -15% | -$28.2K | 0.01% | 227 |
|
|
2023
Q2 | $190K | Sell |
2,743
-253
| -8% | -$18K | 0.01% | 203 |
|
|
2023
Q1 | $223K | Sell |
2,996
-50
| -2% | -$4.19K | 0.02% | 189 |
|
|
2022
Q4 | $284K | Buy |
3,046
+28
| +0.9% | +$2.7K | 0.03% | 168 |
|
|
2022
Q3 | $288K | Sell |
3,018
-27
| -0.9% | -$2.67K | 0.03% | 158 |
|
|
2022
Q2 | $282K | Buy |
3,045
+27
| +0.9% | +$2.63K | 0.03% | 163 |
|
|
2022
Q1 | $305K | Buy |
3,018
+1,314
| +77% | +$138K | 0.03% | 156 |
|
|
2021
Q4 | $176K | Sell |
1,704
-1,329
| -44% | -$123K | 0.02% | 202 |
|
|
2021
Q3 | $252K | Sell |
3,033
-47
| -2% | -$3.94K | 0.03% | 158 |
|
|
2021
Q2 | $257K | Sell |
3,080
-1,885
| -38% | -$154K | 0.03% | 160 |
|
|
2021
Q1 | $373K | Sell |
4,965
-469
| -9% | -$34.2K | 0.04% | 141 |
|
|
2020
Q4 | $371K | Buy |
5,434
+1
| +0% | +$65 | 0.04% | 127 |
|
|
2020
Q3 | $317K | Buy |
5,433
+186
| +4% | +$11.6K | 0.04% | 128 |
|
|
2020
Q2 | $341K | Buy |
5,247
+296
| +6% | +$18.6K | 0.05% | 119 |
|
|
2020
Q1 | $294K | Buy |
4,951
+18
| +0.4% | +$1.2K | 0.05% | 116 |
|
|
2019
Q4 | $358K | Sell |
4,933
-206
| -4% | -$14.5K | 0.05% | 115 |
|
|
2019
Q3 | $324K | Buy |
+5,139
| New | +$305K | 0.05% | 113 |
|
|
2017
Q4 | – | Sell |
-1,390
| Closed | -$113K | – | 153 |
|
|
2017
Q3 | $113K | Sell |
1,390
-1,295
| -48% | -$102K | 0.02% | 138 |
|
|
2017
Q2 | $216K | Sell |
2,685
-445
| -14% | -$35.1K | 0.04% | 120 |
|
|
2017
Q1 | $246K | Sell |
3,130
-1,020
| -25% | -$81.4K | 0.04% | 111 |
|
|
2016
Q4 | $327K | Sell |
4,150
-1,875
| -31% | -$152K | 0.06% | 103 |
|
|
2016
Q3 | $536K | Sell |
6,025
-70
| -1% | -$6.61K | 0.1% | 84 |
|
|
2016
Q2 | $584K | Sell |
6,095
-780
| -11% | -$77.7K | 0.11% | 80 |
|
|
2016
Q1 | $713K | Sell |
6,875
-1,260
| -15% | -$123K | 0.14% | 73 |
|
|
2015
Q4 | $795K | Sell |
8,135
-2,525
| -24% | -$247K | 0.16% | 69 |
|
|
2015
Q3 | $1.03M | Sell |
10,660
-5,370
| -33% | -$565K | 0.21% | 55 |
|
|
2015
Q2 | $1.68M | Sell |
16,030
-470
| -3% | -$48K | 0.33% | 36 |
|
|
2015
Q1 | $1.7M | Buy |
16,500
+390
| +2% | +$39.5K | 0.32% | 43 |
|
|
2014
Q4 | $1.55M | Buy |
16,110
+185
| +1% | +$16.3K | 0.3% | 49 |
|
|
2014
Q3 | $1.27M | Buy |
15,925
+2,735
| +21% | +$216K | 0.25% | 56 |
|
|
2014
Q2 | $994K | Buy |
13,190
+5,830
| +79% | +$441K | 0.2% | 60 |
|
|
2014
Q1 | $551K | Buy |
7,360
+2,055
| +39% | +$145K | 0.11% | 76 |
|
|
2013
Q4 | $380K | Buy |
+5,305
| New | +$341K | 0.08% | 88 |
|
Other funds holding CVS
Acropolis Investment Management's CVS Position: Q4 2024 in Review
Acropolis Investment Management sold out of CVS Health (CVS) in Q4 2024, closing a stake of 1,616 shares — an estimated $102K sold.
Acropolis Investment Management first reported a position in CVS in Q4 2013 and held it in 37 quarters. The position peaked at $1.7M in Q1 2015. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.
- Acropolis Investment Management reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
- Acropolis Investment Management sold 1,616 CVS Health shares in Q4 2024, an estimated $102K.
- Acropolis Investment Management first reported a position in CVS Health in Q4 2013 and held it in 37 quarters.
- Acropolis Investment Management's CVS Health position peaked at $1.7M in Q1 2015.
- 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.
Based on Acropolis Investment Management's 13F filing for Q4 2024, filed 14 Jan 2025.